Sorafenib improves rituximab and ofatumumab efficacy by decreasing the expression of complement regulatory proteins
索拉非尼通过降低补体调节蛋白的表达来提高利妥昔单抗和奥法木单抗的疗效
期刊:Blood Cancer Journal
影响因子:12.9
doi:10.1038/bcj.2015.27
M Dwojak, M Bobrowicz, J Bil, K Bojarczuk, B Pyrzynska, M Siernicka, A Malenda, E Lech-Maranda, W Tomczak, K Giannopoulos, J Golab, M Winiarska
